Sanofi and Regeneron Preemptively Sue Amgen to Protect their New Eczema Drug

Sanofi SA and Regeneron Pharmaceuticals Inc have developed a new injectable drug called Dupixent (known chemically as dupilumab).  Dupixent is said to be a very important drug for the treatment of eczema that causes extreme itching to the skin, with… Continue Reading →

© 2020 Dawn Ellmore Employment Blog — Powered by WordPress

Theme by Anders NorenUp ↑